This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Clinical Program
Race is progressing a robust pipeline of clinical activities for bisantrene to maximise commercialisation and partnership opportunities to benefit cancer patients worldwide.
Preclinical Activities
Continue studies to determine the cardioprotection mechanism of action
Develop the next generation bisantrene with a focus on the m6A RNA opportunity
Continue build of the preclinical data package needed to support pharma transaction/partnering activities
Generate data to enable an FDA IND application